LexDanaLexDanabeta
Inventor

Jun Yang

Inventor
Baltimore, MD, US

Overview

16→
Patents
2002–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 16 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
G01NInvestigating or analysing materials by determining their chemical or physical properties18%
C12NMicroorganisms or enzymes15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%
C07KPeptides6%
B03CMagnetic or electrostatic separation of solid materials from solid materials or fluids3%
LOC063%
PatentTitleYear
10,857,158Anordrin compositions and methods for treating diseases202010,624,874Lasofoxifene modulation of membrane-initiated estrogen signals and methods for tumor treatment202010,557,860Circulating pulmonary hypertension biomarker202010,231,978Anordrin compositions and methods for treating diseases201910,215,764Assay reagents for a neurogranin diagnostic kit201910,213,385Combinational liposome compositions for cancer therapy20199,717,686'Combinational liposome compositions for cancer therapy'20179,709,578'Assay reagents for a neurogranin diagnostic kit'20179,370,489'Combinational liposome compositions for cancer therapy'2016D0682588'Bag dispenser'20137,709,205'14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type'20107,316,907'14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types'20087,022,666'Method of inducing formation of kidney epithelia from mesenchymal precursors'20066,642,050'Three-dimensional cell culture material having sugar polymer containing cell recognition sugar chain'20036,641,708'Method and apparatus for fractionation using conventional dielectrophoresis and field flow fractionation'20036,423,681'Method of inducing formation of kidney epithelia from mesenchymal precursors'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2006Patents assigned to UNIV COLUMBIA (2)· patent assignee history
2002–2006Based in New York, NY, US· patent location history
2003–2010Patents assigned to UNIV TEXAS (3)· patent assignee history
2003–2010Based in Houston, TX, US· patent location history
2013–2019Based in Shanghai, CN· patent location history
2016–2019Patents assigned to MALLINCKRODT LLC (3)· patent assignee history
2016–2019Based in Ballwin, MO, US· patent location history
2017–2020Patents assigned to UNIV JOHNS HOPKINS (3)· patent assignee history
2017–2020Based in Baltimore, MD, US· patent location history
2019–2020Patents assigned to CHANGZHOU RUIMING PHARMACEUTICAL COMPANY LTD (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MALLINCKRODT LLC32016–2019
UNIV JOHNS HOPKINS32017–2020
UNIV TEXAS32003–2010
CHANGZHOU RUIMING PHARMACEUTICAL COMPANY LTD22019–2020
UNIV COLUMBIA22002–2006
Locations
LocationPatentsSpan
Baltimore, Maryland, US32017–2020
Ballwin, MO, US32016–2019
Houston, Texas, US32003–2010
Shanghai, CN22013–2019
New York, New York, US22002–2006